The mechanism of action, pharmacokinetics, and clinical efficacy of carfilzomib for the treatment of multiple myeloma
Author:
Publisher
Informa Healthcare
Subject
Pharmacology,Toxicology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/17425255.2013.817556
Reference24 articles.
1. How to treat elderly patients with multiple myeloma: combination of therapy or sequencing
2. Clinical Pharmacokinetics, Metabolism, and Drug-Drug Interaction of Carfilzomib
3. Epoxomicin, a new antitumor agent of microbial origin.
4. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
5. Total synthesis of the-potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Population pharmacokinetic/pharmacodynamic joint modeling of ixazomib efficacy and safety using data from the pivotal phase III TOURMALINE‐MM1 study in multiple myeloma patients;CPT: Pharmacometrics & Systems Pharmacology;2022-06-13
2. Small Molecule Inhibitors That Target Signal Transduction Pathways Involved in Oxidative Stress-Induced Cancer;Handbook of Oxidative Stress in Cancer: Therapeutic Aspects;2022
3. Small Molecule Inhibitors That Target Signal Transduction Pathways Involved In Oxidative Stress-Induced Cancer;Handbook of Oxidative Stress in Cancer: Therapeutic Aspects;2022
4. Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment;Acta Pharmacologica Sinica;2021-12-10
5. KD-PACE Salvage Therapy for Aggressive Relapsed Refractory Multiple Myeloma, Plasma Cell Leukemia and Extramedullary Myeloma;Clinical Lymphoma Myeloma and Leukemia;2021-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3